Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase and cytokine genes expressed in gastric carcinoma cell line SGC7901

World Journal of Gastroenterology

Volumn 10, Issue 1, 2004, Pages 26-30

  Zhang, Jian Hua ^a   Wan, Ming Xi ^a   Yuan, Jia Ying ^b   Pan, Bo Rong ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC G 418; CYTOKINE; ENDONUCLEASE; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 2; LIPOFECTAMINE; PLASMID VECTOR; PROTEIN; RECOMBINANT PROTEIN; RETROVIRUS VECTOR; THYMIDINE KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS VECTOR;

ARTICLE; CANCER CELL CULTURE; DIGESTION; DRUG EFFECT; FLUORESCENCE MICROSCOPY; GENE CONSTRUCT; GENE EXPRESSION; GENE IDENTIFICATION; GENE INSERTION; GENE STRUCTURE; GENE THERAPY; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNAL RIBOSOME ENTRY SITE; MOLECULAR CLONING; PROTEIN EXPRESSION; STOMACH CARCINOMA; SUICIDE GENE; WESTERN BLOTTING;

EID: 0346685828     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i1.26     Document Type: Article

References (38)

1. Xu CT, Huang LT, Pan BR. Current gene therapy for stomach carcinoma. World J Gastroenterol 2001; 7: 752-759
2. Song ZJ, Gong P, Wu YE. Relationship between the expression of iNOS, VEGF, tumor angiogenesis and gastric cancer. World J Gastroenterol 2002; 8: 591-595
3. Tao HQ, Zou SC. Effect of preoperative regional artery chemotherapy on proliferation and apoptosis of gastric carcinoma cells. World J Gastroenterol 2002; 8: 451-454
4. Han Y, Han ZY, Zhou XM, Shi R, Zheng Y, Shi YQ, Miao JY, Pan BR, Fan DM. Expression and function of classical protein kinase C isoenzymes in gastric cancer cell line and its drug-resistant sublines. World J Gastroenterol 2002; 8: 441-445
5. Wang X, Lan M, Shi YQ, Lu J, Zhong YX, Wu HP, Zai HH, Ding J, Wu KC, Pan BR, Jin JP, Fan DM. Differential display of vincristine-resistance-related genes in gastric cancer SGC7901 cell. World J Gastroenterol 2002; 8: 54-59
6. Shen LZ, Wu WX, Xu DH, Zheng ZC, Liu XY, Ding Q, Hua YB, Yao K. Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene. World J Gastroenterol 2002; 8: 270-275
7. Thomas AL, Steward WP. Recent advances in the nonsurgical treatment of upper gastrointestinal tract tumors. Expert Rev Anticancer Ther 2001; 1: 258-268
8. Narita M, Bahar R, Hatano M, Kang MM, Tokuhisa T, Goto S, Saisho H, Sakiyama S, Tagawa M. Tissue-specific expression of a suicide gene for selective killing of neuroblastoma cells using a promoter region of the NCX gene. Cancer Gene Ther 2001; 8: 997-1002
9. Van Dillen IJ, Mulder NH, Vaalburg W, De Vries EF, Hospers GA. Influence of the bystander effect on HSV-tk/GCV gene therapy. A review. Curr Gene Ther 2002; 2: 307-322
10. Nowak AK, Lake RA, Kindler HL, Robinson BW. New approaches for mesothelioma: Biologics, vaccines, gene therapy, and other novel agents. Semin Oncol 2002; 29: 82-96
11. Qiao J, Doubrovin M, Sauter BV, Huang Y, Guo ZS, Balatoni J, Akhurst T, Blasberg RG, Tjuvahev JG, Chen SH, Woo SL. Tumor-specific transcriptional targeting of suicide gene therapy. Gene Ther 2002; 9: 168-175
12. Engelmann C, Heslan JM, Fabre M, Lagarde JP, Klatzmann D, Panis Y. Importance, mechanisms and limitations of the distant bystander effect in cancer gene therapy of experimental liver tumors. Cancer Lett 2002; 179: 59-69
13. Adachi Y, Matsubara S, Muramatsu T, Curiel DT, Reynolds PN. Midkine promoter-based adenoviral suicide gene therapy to midkine-positive pediatric tumor. J Pediatr Surg 2002; 37: 588-592
14. Pulkkanen KJ, Laukkanen JM, Fuxe J, Kettunen MI, Rehn M, Kannasto JM, Parkkinen JJ, Kauppinen RA, Pettersson RF, Yla-Herttuala S. The combination of HSV-tk and endostatin gene therapy eradicates orthotopic human renal cell carcinomas in nude mice. Cancer Gene Ther 2002; 9: 908-916
15. Floeth FW, Shand N, Bohar H, Prisack HB, Felsberg J, Neuen-Jacob E, Aulich A, Burger KJ, Bock WJ, Weber F. Local inflammation and devascularization-in vivo mechanisms of the "bystander effect" in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma. Cancer Gene Ther 2001; 8: 843-851
16. Warren P, Song W, Holle E, Holmes L, Wei Y, Li J, Wagner T, Yu X. Combined HSV-TK/GCV and secondary lymphoid tissue chemokine gene therapy inhibits tumor growth and elicits potent antitumor CTL response in tumor-bearing mice. Anticancer Res 2002; 22: 599-604
17. Guan J, Ma L, Wei L. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes. Chin Med J 2001; 114: 147-151
18. Hall SJ, Canfield SE, Yan Y, Hassen W, Selleck WA, Chen SH. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer. Gene Ther 2002; 9: 511-517
19. Boucher PD, Ostruszka LJ, Murphy PJ, Shewach DS. Hydroxyurea significantly enhances tumor growth delay in vivo with herpes simplex virus thymidine kinase/ganciclovir gene therapy. Gene Ther 2002; 9: 1023-1030
20. Hayashi K, Hayashi T, Sun HD, Takeda Y. Contribution of a combination of ponicidin and acyclovir/ganciclovir to the anti-tumor efficacy of the herpes simplex virus thymidine kinase gene therapy system. Hum Gene Ther 2002; 10: 415-423
21. Ulrich-Vinther M, Carmidy EE, Goater JJ, S Balle K, O'Keefe RJ, Schwarz EM. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg Am 2002; 84A: 1405-1412
22. Wong ET, Ngoi SM, Lee CG. Improved co-expression of multiple genes in vectors containing internal ribosome entry sites (IRESes) from human genes. Gene Ther 2002; 9: 337-344
23. Cao MM, Pan W, Chen QL, Ma ZC, Ni ZJ, Wu XL, Wu WB, Pan X, Cao GW, Qi ZT. Construction of the eukaryotic expression vector expressing the fusion protein of human endostatin protein and IL3 signal peptide. Shijie Huaren Xiaohua Zazhi 2001; 9: 43-46
24. Pan X, Ke CW, Pan W, Wu WB, Zhang B, He X, Cao GW, Qi ZT. Construction of eukaryotic expression vector carrying IFN-β gene under control of human HBV promoter. Shijie Huaren Xiaohua Zazhi 2000; 8: 520-523
25. Zhang J, Liu YF, Yang SJ, Sun ZW, Qiao Q, Zhang SZ. Construction and expression of mouse/humanized scFv and their fusion to humanized mutant TNFα against hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2000; 8: 616-620
26. Cheng H, Liu YF, Zhang HZ, Shen WA, Zhang SZ. Construction and expression of anti-HCC immunotoxin of sFv-TNF-α and GFP fusion proteins. Shijie Huaren Xiaohua Zazhi 2001; 9: 640-644
27. Chen JP, Lin C, Xu CP, Zhang XY, Wu M. The therapeutic effects of recombinant adenovirus RA538 on human gastric carcinoma cells in vitro and in vivo. World J Gastroenterol 2000; 6: 855-860
28. Feng RH, Zhu ZG, Li JF, Liu BY, Yan M, Yin HR, Lin YZ. Inhibition of human telomerase in MKN-45 cell line by antisense hTR expression vector induces cell apoptosis and growth arrest. World J Gastroenterol 2002; 8: 436-440
29. 7 scFv. World J Gastroenterol 2002; 8: 99-102
30. Guo SY, Gu QL, Liu BY, Zhu ZG, Yin HR, Lin YZ. Experimental study on the treatment of gastric cancer by TK gene combined with mIL-2 gene. Shijie Huaren Xiaohua Zazhi 2000; 8: 974-978
31. Huang H, Wang A. The adenovirus-mediated HSV-TK/GCV suicide gene system in the treatment of tongue carcinoma cell line. Zhonghua Kouqiang Yiyue Zazhi 2001; 36: 457-460
32. Gao G, Huang T, Chen S. In vitro and in vivo bystander effect of adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Zhonghua Waike Zazhi 2002; 40: 301-303
33. Majumdar AS, Zolotorey A, Samuel S, Tran K, Vertin B, Hall-Meier M, Antoni BA, Adeline E, Philip M, Philip R. Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model. Cancer Gene Ther 2000; 7: 1086-1099
34. Kobayashi T, Kida Y, Kaneko T, Pastan I, Kobayashi K. Efficient ablation by immunotoxin-mediated cell targeting of the cell types that express human interleukin-2 receptor depending on the internal ribosome entry site. J Gene Med 2001; 3: 505-510
35. Royal RE, Kershaw MH, Reeves ME, Wang G, Daly T, Treisman J, Lam J, Hwu P. Increased functional expression of transgene in primary human lymphocytes using retroviral vectors modified with IRES and splicing motifs. Gene Ther 2002; 9: 1085-1092
36. Wang SI, Mukhtar H. A high-efficiency translational control element with potential for cancer gene therapy. Int J Oncol 2002; 20: 1269-1274
37. Qiao J, Roy V, Girard MH, Caruso M. High translation efficiency is mediated by the encephalomyocarditis virus internal ribosomal entry sites if the natural sequence surrounding the eleventh AUG is retained. Hum Gene Ther 2002; 13: 881-887
38. Zhang X, Wu J, Li X, Fu L, Gao D, Bai H, Liu X. Effects of recombinant human bone morphogenic protein-2 and hyaluronic acid on invasion of brain glioma in vivo. Zhonghua Yixue Zazhi 2002; 82: 90-93